Table 3

Uptake of doxorubicin conjugate and its active metabolites in LNCaP human prostate tumor cells

CompoundCell-to-Medium Ratio
Doxorubicin192  ± 3
Leucine-doxorubicin17.2  ± 3.8
Doxorubicin conjugate3.36  ± 0.40

Results are shown as mean ± S.D. of triplicate determinations.